Skip to main content

Advertisement

Log in

ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells)

  • Brief Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Introduction

Goblet cell carcinoma (GCC) is an appendicular neoplasia representing less than 5% of all appendicular tumors, found in 0.3–0.9% of the appendectomies, 35–58% of all appendicular neoplasms, and less than 14% of malign appendix tumors. The most frequent clinical presentation is abdominal pain associated with a picture of acute appendicitis.

Materials and methods

We present 3 clinical cases of appendix GCC, 2 subjected to cytoreductory surgery plus intraperitoneal hyperthermic chemotherapy and a third, who is currently receiving neoadjuvant treatment with a good response to chemotherapy and who will be offered the same treatment as the first two patients. Given the unpredictable behavior of these tumors, the use of molecular markers could help us to predict their behavior and prognosis. In this context, the TP73 gene would make an interesting putative marker. ∆Np73 has been described as overexpressed in a great variety of tumor types including colon cancer and this up-regulation is associated with a poor prognosis. To evidence its role in this malignancy, we evaluate here the status of ∆Np73 in the primary tumor and normal counterpart tissues, in the metastatic implants and in healthy areas of the peritoneum from the appendicular GCC patients. In addition, we checked the expression levels of this p73 variant in the tumor and normal tissue of 26 patients with colon cancer.

Results

Remarkably, 2 patients showed significant ∆Np73 down-regulation in both the primary tumor and the implants. Case 1 presented a fourfold decrease of levels in the primary tumor and 20-fold decrease in the implants. Case 2 showed a seven- and fourfold down-regulation in the primary tumor and implants, respectively. However, Case 3 showed an up-regulation of 53- and threefold in the primary tumor and implants, respectively.

Conclusion

Goblet cell carcinoma of the appendix is very rate. It tends to seed throughout the peritoneum, making aggressive surgical cytoreduction and chemotherapy viable treatment options. Investigation into the molecular basis of these tumors may improve the diagnosis, prognosis and therapeutic decisions regarding these patients. ∆Np73 seems a good candidate for further analysis in longer series.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Tang LH, Shia J, Soslow RA, Dhall D, Wong WD, O’Reilly E, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol. 2008;32(10):1429–43.

    Article  PubMed  Google Scholar 

  2. Reid MD, Basturk O, Shaib WL, Xue Y, Balci S, Choi HJ, et al. Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases. Mod Pathol. 2016;29(10):1243–53.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Madani A, Van der Bilt JDW, Consten ECJ, Menno R, et al. Perforation in appendiceal well-differentiated carcinoid and goblet cell tumors: impact on prognosis? A systematic review. Ann Surg Oncol. 2015;22:959–65.

    Article  PubMed  Google Scholar 

  4. Ibrahim U, Valecha G, Garcia G, Saqib A, Wrzolek M, Dhar M. adenocarcinoma ex-goblet cell carcinoidof the appendix: a case report and overview of the disease. J Gastrointest Cancer. 2017. https://doi.org/10.1007/s12029-017-9926-9.

    Article  Google Scholar 

  5. Chetty R, Klimstra DS, Henson DE, Albores-Saavedra J. Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix. Am J Surg Pathol. 2010;34(8):1163–7.

    Article  PubMed  Google Scholar 

  6. Holt N, Grønbæk H. Goblet cell carcinoids of the appendix. Sci World J. 2013. https://doi.org/10.1155/2013/543696.

    Article  Google Scholar 

  7. Subbuswamy SG, Gibbs NM, Ross CF, Morson BC. Goblet cell carcinoid of the appendix. Cancer. 1974;34(2):338–44.

    Article  CAS  PubMed  Google Scholar 

  8. Reid MD, Basturk O, Shaib WL, Xue Y, Balci S, Choi HJ, et al. Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma)is a morphologically distinct entity with highlyaggressive behavior and frequent associationwith peritoneal/intra-abdominal dissemination. Mod Pathol. 2016;29:1243–53.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bucher P, Gervaz P, Ris F, Oulhaci W, Egger JF, Morel P. Surgical treatment of appendiceal adenocarcinoid (goblet cell carcinoid). World J Surg. 2005;29:1436e9.

    Article  Google Scholar 

  10. Kanthan R, Saxena A, Kanthan SC. Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med. 2001;125(3):386–90.

    CAS  PubMed  Google Scholar 

  11. Rossi RE, Luong TV, Caplin ME, Thirlwell C, Meyer T, Garcia-Hernandez J, et al. Goblet cell appendiceal tumors. Management dilemmas and long-term outcomes. Surg Oncol. 2015;24:47e53.

    Article  Google Scholar 

  12. Soldevilla B, Rodríguez M, San Millán C, García V, Fernández-Periañez R, Gil-Calderón B, et al. Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival. Hum Mol Genet. 2014;23(2):467–78.

    Article  CAS  PubMed  Google Scholar 

  13. Soldevilla B, Millán CS, Bonilla F, Domínguez G. The TP73 complex network: ready for clinical translation in cancer? Genes Chromosomes Cancer. 2013;52(11):989–1006.

    Article  CAS  PubMed  Google Scholar 

  14. Soldevilla B, Díaz R, Silva J, Campos-Martín Y, Muñoz C, García V, et al. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients. Clin Cancer Res. 2011;17(18):6029–39.

    Article  CAS  PubMed  Google Scholar 

  15. Wang HL, Dhall D. Goblet or signet ring cells that is the question. Adv Anat Pathol. 2009;16(4):247–54.

    Article  PubMed  Google Scholar 

  16. Alsaad KO, Serra S, Chetty R. Combined goblet cell carcinoid and mucinous cystadenoma of the vermiform appendix. World J Gastroenterol. 2009;15(27):3431–3.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ramnani DM, Wistuba II, Behrens C, Gazdar AF, Sobin LH, Albores-Saavedra J, et al. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer. 1999;86:14–21.

    Article  CAS  PubMed  Google Scholar 

  18. Hristov AC, Young RH, Vang R, Yemelyanova AV, Seidman JD, Ronnett BMO. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases. Am J Surg Pathol. 2007;31(10):1502–11.

    Article  PubMed  Google Scholar 

  19. Taggart MW, Abraham SC, Overman MJ, Mansfield PF, Rashid A. Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. Arch Pathol Lab Med. 2015;139(6):78–90.

    Article  Google Scholar 

  20. Rossi RE, Luong TV, Caplin ME, Thirlwell C, Meyer T, Garcia-Hernandez J, et al. Goblet cell appendiceal tumors–management dilemmas and long-term outcomes. Surg Oncol. 2015.

  21. Leea KS, Tangb LH, Shiab J, Patyc PB, Weiserc MR, Guillemc JG, et al. Goblet cell carcinoid neoplasm of the appendix: clinical and CT features. Eur J Radiol. 2013;82:85–9.

    Article  Google Scholar 

  22. Shaib WL, Martin LK, Choi M, Chen Z, Krishna K, Kim S, et al. Hyperthermic intraperitoneal chemotherapy following cytoreductivesurgery improves outcome in patients with primary appendiceal mucinous adenocarcinoma: a pooled analysis from three tertiary care centers. Oncologist. 2015;20:907–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination. Clin Colon Rectal Surg. 2005;18(3):204–14.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Cashin P, Nygren P, Hellman P, Granberg D, Andr easson H, Mahteme H. Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival. Clin Colorectal Cancer. 2011;10:108e12.

    Article  CAS  Google Scholar 

  25. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to pseudomyxoma peritonei”. Am J Surg Pathol. 1995;19:1390–408.

    Article  CAS  PubMed  Google Scholar 

  26. Sanz CM, Sugarbaker PH. Adenocarcinoid of appendiceal origin causing peritoneal carcinomatosis. Reg Cancer Treat. 1994;7:211–6.

    Google Scholar 

  27. Mahteme H, Sugarbaker PH. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg. 2004;91:1168–70.

    Article  CAS  PubMed  Google Scholar 

  28. Pham TH, Wolf B, Abraham SC, Drelichman E. Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience. Ann Surg Oncol. 2017;13(3):370–6.

    Article  Google Scholar 

  29. Gagné F, Fortin P, Dufour V, Delage C. Tumors of the appendix associating histologic features of carcinoid and adenocarcinoma. Ann d’Anat Pathol. 1969;14(4):393–406.

    Google Scholar 

  30. Sobin Leslie H, Albores-Saavedra Jorge. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med. 2001;125(3):386–90.

    Google Scholar 

  31. Domínguez G, García JM, Peña C, Silva J, García V, Martínez L, et al. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1. J Clin Oncol. 2006;24(5):805–15.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge ISCIII, FIS, FEDER and Cátedra UAM-ROCHE de Medicina de Innovación for funding our current research through the PI18/00473 and CIBERONIC. Gemma Domínguez and Nuria Rodriguez have received research grants from Roche Farma SA.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to M. I. Prieto-Nieto or G. Domínguez.

Ethics declarations

Conflict of interest

Nuria Rodríguez and Gemma Domínguez are funded by Roche Farma through “Cátedra de Medicina de Innovación UAM-ROCHE”, for conducting teaching and research programs in the context of the Universidad Autónoma de Madrid. The other authors declare no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prieto-Nieto, M.I., Pastor, D., Rodríguez-Cobos, J. et al. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells). Clin Transl Oncol 21, 1432–1439 (2019). https://doi.org/10.1007/s12094-019-02091-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-019-02091-1

Keywords

Navigation